Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Booz Allen Hamilton Holding Corporation (BAH) vs Oscar Health Inc (OSCR) Price & Performance

Booz Allen Hamilton Holding CorporationTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Booz Allen Hamilton Holding Corporation vs Oscar Health Inc — how do they compare? Booz Allen Hamilton Holding Corporation trades at $78.46 (market cap $9.45B), while Oscar Health Inc trades at $29.51 (market cap $8.63B). The key difference: Booz Allen Hamilton Holding Corporation and Oscar Health Inc are close in size by market cap, and Booz Allen Hamilton Holding Corporation pays a 3% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

BAHOSCR
Market Cap
$9.45B$8.63B
Sector
IndustrialsHealth
52-Week High
$111.63$32.18
52-Week Low
$59.71$10.85
Enterprise Value
$13.07B$4.99B
Dividend Yield
3%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton (BAH) trades at $77.93, up 0.04% on the day, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a 7.01% net margin and 68.11% ROE, while valuation ratios like P/E of 12.33 and P/S of 0.86 appear attractive. Recent Q2 2026 earnings beat estimates at $1.81 per share, and the company maintains consistent dividend payments, reflecting financial stability.

Outlook remains positive with analyst consensus price target of $84.67, though risks include high debt levels and civil revenue weakness. Growth in national security and AI investments offers upside, but investors should monitor leverage and sector-specific headwinds for balanced exposure.

Oscar Health Inc

Oscar Health (OSCR) trades at $29.11, up 5.2% with strong recent earnings momentum, beating estimates in Q1 and Q2 2026. The stock shows bearish technical signals but benefits from record profitability and raised 2026 guidance. Revenue surged 70% to $4.9 billion in H1 2026, with net income turning positive at $551 million versus a 2025 loss. Valuation remains attractive with P/S of 0.53, suggesting potential undervaluation versus sector peers.

Outlook is positive given membership growth and cost discipline, but risks include medical cost volatility and competitive pressures. Analyst consensus price target of $32.50 implies 12% upside, though technical resistance near $30 may limit near-term gains. Execution on guidance and sustained margin expansion are key catalysts.

Returns comparison

Trailing returns across standard periods

About Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.

Read more on BAH

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR